AI-Driven Prediction of Dialysis Outcome With EHR
Condition(s) studied
Investigational drug(s) / intervention(s)
AI-assisted Predictive Model for Dialysis Outcomes: This study utilizes an AI-assisted predictive model that analyzes multimodal data from electronic health records, including medical history, laboratory results, dialysis treatment details, and clinical observations, to predict outcomes for dialysis patients. The model employs deep learning algorithms to predict mortality risk, intermediate outcomes such as anemia, blood pressure control, nutrition, and calcium-phosphate metabolism, and helps identify early signs of deterioration. The intervention is not a direct treatment or procedure but aims to develop a tool for predicting patient outcomes and optimizing treatment strategies to improve overall health and survival rates for dialysis patients.
Study summary
This is a multi-center, clinical study designed to evaluate the application and effectiveness of an AI-assisted predictive model for outcome of dialysis patients, leveraging multimodal health data.
Eligibility
Primary outcome measure(s)
- Mortality Prediction Accuracy — 1 year
The ability of the AI-assisted predictive model to accurately predict the risk of mortality in dialysis patients. Prediction accuracy will be assessed using the Area Under the Curve (AUC), F1 score, and sensitivity/specificity. The model will be evaluated by comparing the predicted mortality risk with actual outcomes (i.e., whether patients survived or passed away during the study period).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| General Hospital of PLA | Beijing | Beijing Municipality | Recruiting |
More The Eye Hospital of Wenzhou Medical University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06791447 on ClinicalTrials.gov ↗ ← All trials in China